summary
Introduced
10/01/2020
10/01/2020
In Committee
10/01/2020
10/01/2020
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
Requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. Specifically, HHS must enter into contracts of up to three years for entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.
AI Summary
This bill, the Essential Medicines Strategic Stockpile Act of 2020, requires the Department of Health and Human Services (HHS) to create a pilot program with private entities to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of up to 50 generic drugs at risk of shortage. The bill establishes various program requirements, including that each stockpile must contain a 6-month supply of each drug, and that the stockpile must be cycled to the commercial market to avoid product expiration. The bill also requires annual evaluations by the Government Accountability Office to review the likely costs, savings, and effectiveness of the program.
Committee Categories
Business and Industry
Sponsors (2)
Last Action
Referred to the House Committee on Energy and Commerce. (on 10/01/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/house-bill/8479/all-info |
| BillText | https://www.congress.gov/116/bills/hr8479/BILLS-116hr8479ih.pdf |
| Bill | https://www.congress.gov/116/bills/hr8479/BILLS-116hr8479ih.pdf.pdf |
Loading...